G&E Herbal Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 08, 2021 at 05:46 pm EST
Share
G&E Herbal Biotechnology Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 7.57 million compared to TWD 9.77 million a year ago. Net loss was TWD 3.08 million compared to TWD 3.36 million a year ago. Basic loss per share from continuing operations was TWD 0.06 compared to TWD 0.06 a year ago.
For the nine months, sales was TWD 19.42 million compared to TWD 18.92 million a year ago. Net loss was TWD 11.05 million compared to TWD 12.41 million a year ago. Basic loss per share from continuing operations was TWD 0.2 compared to TWD 0.22 a year ago.
G&E Herbal Biotechnology Co., Ltd is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of health care food products, functional skin care products and pharmaceutical products. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The Company also provides botanical medicines for cancers and liver diseases. The Company distributes its products within domestic market and to overseas markets.